These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11006499)

  • 1. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints.
    Skarsgård C; E Berg G; Ekblad S; Wiklund I; Hammar ML
    Maturitas; 2000 Aug; 36(2):123-30. PubMed ID: 11006499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
    Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
    Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW; Dailey ME; Rockhill B; Tipping D; Naughton MJ; Shumaker SA
    Psychosom Med; 2005; 67(1):98-104. PubMed ID: 15673630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
    Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
    Nielsen TF; Ravn P; Pitkin J; Christiansen C
    Maturitas; 2006 Jan; 53(2):184-90. PubMed ID: 16368471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: a randomized trial.
    Tansupswatdikul P; Chaikittisilpa S; Jaimchariyatam N; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    Climacteric; 2015 Apr; 18(2):198-204. PubMed ID: 25242569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women.
    Wiklund I; Berg G; Hammar M; Karlberg J; Lindgren R; Sandin K
    Maturitas; 1992 Mar; 14(3):225-36. PubMed ID: 1508062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen effects on postural balance in postmenopausal women without vasomotor symptoms: a randomized masked trial.
    Ekblad S; Lönnberg B; Berg G; Odkvist L; Ledin T; Hammar M
    Obstet Gynecol; 2000 Feb; 95(2):278-83. PubMed ID: 10674594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol.
    Notelovitz M; Mattox JH
    Menopause; 2000; 7(5):310-7. PubMed ID: 10993030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF;
    Menopause; 2003; 10(6):516-21. PubMed ID: 14627859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of hormone replacement therapy on the quality of life in postmenopausal women with hypertension].
    Czarnecka D; Klocek M; Betkowska-Korpała B; Jankowski P; Olszanecka A; Kawecka-Jaszcz K
    Przegl Lek; 2000; 57(7-8):397-401. PubMed ID: 11109313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy.
    Savolainen-Peltonen H; Hautamäki H; Tuomikoski P; Ylikorkala O; Mikkola TS
    Menopause; 2014 Jul; 21(7):732-9. PubMed ID: 24219882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone.
    Mirkin S; Graham S; Revicki DA; Bender RH; Bernick B; Constantine GD
    Menopause; 2019 Jan; 26(6):637-642. PubMed ID: 30601452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints.
    von Holst T; Salbach B
    Maturitas; 2000 Feb; 34(2):143-53. PubMed ID: 10714909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.
    Rozenbaum H; Chevallier O; Moyal M; Durand G; Perineau M; This P;
    Climacteric; 2002 Sep; 5(3):249-58. PubMed ID: 12419083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.